Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2,048,819,940
-
Total 13F shares
-
1,826,735
-
Share change
-
-2,227,972
-
Total reported value
-
$4,602,033
-
Price per share
-
$2.52
-
Number of holders
-
18
-
Value change
-
-$3,146,842
-
Number of buys
-
10
-
Number of sells
-
8
Institutional Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q4 2020
As of 31 Dec 2020,
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,826,735 shares.
The largest 10 holders included
MORGAN STANLEY, Parkman Healthcare Partners LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., CITADEL ADVISORS LLC, LPL Financial LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, Schonfeld Strategic Advisors LLC, Cutter & CO Brokerage, Inc., and Thomasville National Bank.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.